LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Universidad Autónoma de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Universidad Autónoma de Madrid (10)
2024
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97
2014
-
Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Clinical and Translational Oncology, Vol. 17, Núm. 2, pp. 103-112
-
MicroRNA-dependent regulation of transcription in non-small cell lung cancer
PLoS ONE, Vol. 9, Núm. 3
2012
2007
-
Gene expression of ERCC1 as a novel prognostic marker in advanced bladder cancer patients receiving cisplatin-based chemotherapy
Annals of Oncology, Vol. 18, Núm. 3, pp. 522-528
-
Setting the benchmark for tailoring treatment with EGFR tyrosine kinase inhibitors
Future Oncology, Vol. 3, Núm. 3, pp. 277-283
2005
-
A phase I, dose-finding study of irinotecan (CPT-11) short i.v. infusion combined with fixed dose of 5-fluorouracil (5-FU) protracted i.v. infusion in adult patients with advanced solid tumours
Cancer Chemotherapy and Pharmacology, Vol. 55, Núm. 5, pp. 453-460
2002
-
Phase II multicentre study of docetaxel plus cisplatin in patients with advanced urothelial cancer
British Journal of Cancer, Vol. 86, Núm. 3, pp. 326-330
-
Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine
Cancer, Vol. 95, Núm. 4, pp. 751-757